These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 11406153)

  • 1. A simple and efficient method for the monitoring of antigen-specific T cell responses using peptide pool arrays in a modified ELISpot assay.
    Tobery TW; Wang S; Wang XM; Neeper MP; Jansen KU; McClements WL; Caulfield MJ
    J Immunol Methods; 2001 Aug; 254(1-2):59-66. PubMed ID: 11406153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of T-cell epitopes using ELISpot and peptide pool arrays.
    Tobery TW; Caulfield MJ
    Methods Mol Med; 2004; 94():121-32. PubMed ID: 14959826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of CD4(+)- and CD8(+)-T-cell responses to human papillomavirus type 1 antigens expressed at various stages of the virus life cycle by using an enzyme-linked immunospot assay of gamma interferon release.
    Steele JC; Roberts S; Rookes SM; Gallimore PH
    J Virol; 2002 Jun; 76(12):6027-36. PubMed ID: 12021335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-10 mediates suppression of the CD8 T cell IFN-gamma response to a novel viral epitope in a primed host.
    Liu XS; Xu Y; Hardy L; Khammanivong V; Zhao W; Fernando GJ; Leggatt GR; Frazer IH
    J Immunol; 2003 Nov; 171(9):4765-72. PubMed ID: 14568953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
    Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
    Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel approach of direct ex vivo epitope mapping identifies dominant and subdominant CD4 and CD8 T cell epitopes from Listeria monocytogenes.
    Geginat G; Schenk S; Skoberne M; Goebel W; Hof H
    J Immunol; 2001 Feb; 166(3):1877-84. PubMed ID: 11160235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a ras oncogene peptide that contains both CD4(+) and CD8(+) T cell epitopes in a nested configuration and elicits both T cell subset responses by peptide or DNA immunization.
    Bristol JA; Orsini C; Lindinger P; Thalhamer J; Abrams SI
    Cell Immunol; 2000 Nov; 205(2):73-83. PubMed ID: 11104579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides.
    Zwaveling S; Ferreira Mota SC; Nouta J; Johnson M; Lipford GB; Offringa R; van der Burg SH; Melief CJ
    J Immunol; 2002 Jul; 169(1):350-8. PubMed ID: 12077264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2.
    Posavad CM; Magaret AS; Zhao L; Mueller DE; Wald A; Corey L
    Vaccine; 2011 Sep; 29(40):7058-66. PubMed ID: 21801778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of overlapping peptide sets for detection of antiviral CD8 and CD4 T cell responses.
    Draenert R; Altfeld M; Brander C; Basgoz N; Corcoran C; Wurcel AG; Stone DR; Kalams SA; Trocha A; Addo MM; Goulder PJ; Walker BD
    J Immunol Methods; 2003 Apr; 275(1-2):19-29. PubMed ID: 12667667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Normalizing ELISPOT responses to T-cell counts: a novel approach for quantification of HCMV-specific CD4(+) and CD8(+) T-cell responses in kidney transplant recipients.
    Calarota SA; Chiesa A; Scaramuzzi L; Adzasehoun KM; Comolli G; Mangione F; Esposito P; Baldanti F
    J Clin Virol; 2014 Sep; 61(1):65-73. PubMed ID: 24961915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-helper epitopes identified within the E6 transforming protein of cervical cancer-associated human papillomavirus type 16.
    Azoury-Ziadeh R; Herd K; Fernando GJ; Frazer IH; Tindle RW
    Viral Immunol; 1999; 12(4):297-312. PubMed ID: 10630789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitive detection of human papillomavirus type 16 E7-specific T cells by ELISPOT after multiple in vitro stimulations of CD8+ T cells with peptide-pulsed autologous dendritic cells.
    Cools N; Ponsaerts P; Lenjou M; Nijs G; Van Bockstaele DR; Van Tendeloo VF; Berneman ZN
    Mol Cancer; 2006 Oct; 5():49. PubMed ID: 17067378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease-stage variance in functional CD4(+) T-cell responses against novel pan-human leukocyte antigen-D region presented human papillomavirus-16 E7 epitopes.
    Warrino DE; Olson WC; Knapp WT; Scarrow MI; D'Ambrosio-Brennan LJ; Guido RS; Edwards RP; Kast WM; Storkus WJ
    Clin Cancer Res; 2004 May; 10(10):3301-8. PubMed ID: 15161683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence, immune specificity, and functional ability of murine mutant ras epitope-specific CD4(+) and CD8(+) T lymphocytes following in vivo adoptive transfer.
    Bristol JA; Schlom J; Abrams SI
    Cell Immunol; 1999 May; 194(1):78-89. PubMed ID: 10357883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The simultaneous ex vivo detection of low-frequency antigen-specific CD4+ and CD8+ T-cell responses using overlapping peptide pools.
    Singh SK; Meyering M; Ramwadhdoebe TH; Stynenbosch LF; Redeker A; Kuppen PJ; Melief CJ; Welters MJ; van der Burg SH
    Cancer Immunol Immunother; 2012 Nov; 61(11):1953-63. PubMed ID: 22491788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antigenic epitopes fused to cationic peptide bound to oligonucleotides facilitate Toll-like receptor 9-dependent, but CD4+ T cell help-independent, priming of CD8+ T cells.
    Schirmbeck R; Riedl P; Zurbriggen R; Akira S; Reimann J
    J Immunol; 2003 Nov; 171(10):5198-207. PubMed ID: 14607920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and treatment of cervical cancer by a single administration of human papillomavirus peptide vaccine with CpG oligodeoxynucleotides as an adjuvant in vivo.
    Yang Y; Che Y; Zhao Y; Wang X
    Int Immunopharmacol; 2019 Apr; 69():279-288. PubMed ID: 30743204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency.
    Hung CF; Tsai YC; He L; Wu TC
    Mol Ther; 2007 Jun; 15(6):1211-9. PubMed ID: 17356542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.